Quick Takeaways
- William J. Link PhD has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $27,537,669.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of William J. Link PhD
- Location
- San Francisco, CA
- Summary
- The estimated net worth of William J. Link PhD is at least $27,537,669 dollars as of 18 Mar 2026. William J. Link PhD is the Director of Tarsus Pharmaceuticals, Inc. and owns shares of Tarsus Pharmaceuticals, Inc. (TARS) stock worth about $8.17M. William J. Link PhD is the Director of LENSAR, Inc. and owns shares of LENSAR, Inc. (LNSR) stock worth about $7.65M. William J. Link PhD is the Director of GLAUKOS Corp and owns shares of GLAUKOS Corp (GKOS) stock worth about $5.48M. William J. Link PhD is the Director of Oyster Point Pharma, Inc. and owns shares of Oyster Point Pharma, Inc. stock worth about $5.47M. William J. Link PhD is the Director of RxSight, Inc. and owns shares of RxSight, Inc. (RXST) stock worth about $771.9K.
- Signature
- /s/ Scott Sieckert, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow William J. Link PhD and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Tarsus Pharmaceuticals, Inc. ($8,169,107).
- Past-year value change for that position: -$4,270,109.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of William J. Link PhD
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | Director | $8,169,107 | -$4,270,109 | -34% | 16 Mar 2026 |
| LNSR | LENSAR, Inc. | Director | $7,648,403 | 23 May 2025 | ||
| GKOS | GLAUKOS Corp | Director | $5,480,783 | 03 Jun 2021 | ||
| OYST | Oyster Point Pharma, Inc. | Director | $5,467,492 | 05 Jan 2022 | ||
| RXST | RxSight, Inc. | Director | $771,884 | 03 Jun 2025 |
Insider Transactions Reported by William J. Link PhD:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.